Zobrazeno 1 - 10
of 11
pro vyhledávání: '"T. J. Stinson"'
Autor:
Alfred Rademaker, Jane N. Winter, P Frey, A Traynor, T. J. Stinson, E Ferdman, K O'Gara, Sara J. Knight, Charles L. Bennett, Amy K. Siston
Publikováno v:
Bone Marrow Transplantation. 30:741-748
Our goal was to compare direct and indirect medical costs and quality of life associated with inpatient vs outpatient autologous hematopoietic stem cell transplantation (AuHSCT). Twenty-one sequential outpatients and 26 inpatients were enrolled on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356e18b9925ba7b56c0585ac5971bf77
https://doi.org/10.1038/sj.bmt.1703676
https://doi.org/10.1038/sj.bmt.1703676
Autor:
Cecilia Tomori, T. J. Stinson, Charles L. Bennett, Benjamin Djulbegovic, Kirstin S. Knox, Jared R. Adams
Publikováno v:
Annals of Oncology. 11:1591-1595
Purpose Our prior study found that pharmaceutical-sponsored and non-profit sponsored analyses differed in their published assessments of the economic value of six new oncology drugs. In this study, we expand on our earlier findings and evaluate the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3210d2fd0973cab701a8c437d9c3aeb
https://doi.org/10.1023/a:1008309817708
https://doi.org/10.1023/a:1008309817708
Autor:
Edward A. Stadtmauer, Hillard M. Lazarus, L. Kaminer, Robert M. Golub, T. J. Stinson, William R. Friedenberg, Jacob M. Rowe, Charles L. Bennett, R. W. Marsh, Martin S. Tallman
Publikováno v:
Annals of Oncology. 10:177-182
Summary Purpose Considerable morbidity and mortality and costs occur during induction therapy for acute myeloid leukemia (AML). Colony-stimulating factors (CSFs) can shorten neutropenia, and may lower costs. We performed a cost-minimization analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16c91b2e5fee65b22d427d08ba2e306a
https://doi.org/10.1023/a:1008318930947
https://doi.org/10.1023/a:1008318930947
Autor:
David M. Aboulafia, Stewart S, von Roenn J, Robert M. Golub, T. J. Stinson, Johannes R. Bogner, Charles L. Bennett, Frank-D. Goebel
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18:460-465
Liposomal formulations have been shown to alter the efficacy and toxicity profiles of anthracylines for patients with HIV-related advanced Kaposi's sarcoma (KS). Using decision-analysis models, the costs and cost-effectiveness of the two U.S. Food an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5cf68af8d1fd358b1219b10f7c935a
https://doi.org/10.1097/00042560-199808150-00007
https://doi.org/10.1097/00042560-199808150-00007
Publikováno v:
Bone marrow transplantation. 26(6)
Hematopoietic colony-stimulating factors (CSF) decrease the duration of neutropenia following stem cell transplantation (SCT). With CSF-mobilized allogeneic blood SCT (alloBSCT), the yields of CD34+ cells are several-fold higher than in other SCT set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb527fd8df25beffa78f69fc0f6a3eab
https://pubmed.ncbi.nlm.nih.gov/11041569
https://pubmed.ncbi.nlm.nih.gov/11041569
Publikováno v:
Medical and pediatric oncology. 34(2)
Growth factor use has been shown to ameliorate chemotherapy-induced neutropenia, leading to shorter hospital stays and lower use of parenteral antibiotics, two costly areas of cancer treatment. Prior reports on pediatric patients have shown evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::168deaab5e2afd73548f70ce9d36d63e
https://pubmed.ncbi.nlm.nih.gov/10657867
https://pubmed.ncbi.nlm.nih.gov/10657867
Autor:
C L, Bennett, T J, Stinson
Publikováno v:
Cancer treatment and research. 102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ac7cb351f3ff70947235228e88cfda8
https://pubmed.ncbi.nlm.nih.gov/10650485
https://pubmed.ncbi.nlm.nih.gov/10650485
Publikováno v:
Cancer investigation. 17(8)
Currently used options for salvage therapy for epithelial ovarian cancer include intravenously administered paclitaxel or topotecan and orally administered altretamine or etoposide. The response rates for these agents are similar (14-26%), whereas th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c4c7e0527bec9a874e2e3aaedacba71
https://pubmed.ncbi.nlm.nih.gov/10592762
https://pubmed.ncbi.nlm.nih.gov/10592762
Autor:
Z. S. Pavletic, Michael R. Bishop, Orit Almagor, Teresa M. Waters, Charles L. Bennett, Stefano R. Tarantolo, T. J. Stinson
Publikováno v:
Bone marrow transplantation. 24(5)
Allogeneic peripheral blood stem cell transplantation (alloPBSCT) is an emerging technology. As this technology develops, transplant centers are concerned with looking for technologic advances that will result in improvements in clinical outcomes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e52cab062bc12aaeb0e4aee235e69d
https://pubmed.ncbi.nlm.nih.gov/10482942
https://pubmed.ncbi.nlm.nih.gov/10482942
Autor:
C L, Bennett, T J, Stinson, M S, Tallman, E A, Stadtmauer, R W, Marsh, W, Friedenberg, H M, Lazarus, L, Kaminer, R M, Golub, J M, Rowe
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 10(2)
Considerable morbidity and mortality and costs occur during induction therapy for acute myeloid leukemia (AML). Colony-stimulating factors (CSFs) can shorten neutropenia, and may lower costs. We performed a cost-minimization analysis of granulocyte m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c94a486ba90431cc0b68b03dfc19bc3
https://pubmed.ncbi.nlm.nih.gov/10093686
https://pubmed.ncbi.nlm.nih.gov/10093686